Efficacy and Safety of LCZ696, a First-in-Class Angiotensin Receptor Neprilysin Inhibitor, in Asian Patients With Hypertension

标题
Efficacy and Safety of LCZ696, a First-in-Class Angiotensin Receptor Neprilysin Inhibitor, in Asian Patients With Hypertension
作者
关键词
-
出版物
HYPERTENSION
Volume 63, Issue 4, Pages 698-705
出版商
Ovid Technologies (Wolters Kluwer Health)
发表日期
2014-01-21
DOI
10.1161/hypertensionaha.113.02002

向作者/读者发起求助以获取更多资源

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now